CANIFLAM-S is a specialized oral suspension combining Meloxicam and Serratiopeptidase, designed to provide effective relief from pain and inflammation. Meloxicam, a selective NSAID, targets inflammation with reduced gastrointestinal side effects, while Serratiopeptidase enhances anti-inflammatory action by breaking down inflammatory mediators. This combination offers a synergistic approach to managing conditions such as musculoskeletal pain, postoperative inflammation, and arthritis, ensuring improved patient comfort and mobility. The oral suspension format allows for easy administration and precise dosing, ideal for patients with difficulty swallowing tablets.